Expert Opinion on Investigational Drugs
-
Publication Venue For
- Tolvaptan: A Selective Vasopressin type 2 (V2) Receptor Antagonist in Congestive Heart Failure. 15:533-540. 2006
- Gut peptides in the treatment of diabetes mellitus.. 13:177-188. 2004
- Neuroinflammatory mechanisms in Alzheimer's disease: New opportunities for drug discovery. 5:449-455. 1996
- Section review: Cardiovascular & renal: Novel antiplatelet agents: The glycoprotein IIb/IIIa inhibitors. 4:1033-1044. 1995
- Early versus delayed zidovudine in the management of HIV infection. 3:809-819. 1994